Liposome-encapsulated plasmid DNA of telomerase-specific oncolytic adenovirus with stealth effect on the immune system-Reference-Cited by-同舟云学术

Liposome-encapsulated plasmid DNA of telomerase-specific oncolytic adenovirus with stealth effect on the immune system

Published:2017-10-26 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Aoyama Katsuyuki,Kuroda Shinji,Morihiro Toshiaki,Kanaya Nobuhiko,Kubota Tetsushi,Kakiuchi Yoshihiko,Kikuchi Satoru,Nishizaki Masahiko,Kagawa Shunsuke,Tazawa Hiroshi^ORCID,Fujiwara Toshiyoshi

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-14717-x.pdf

Reference36 articles.

1. Kirn, D. Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of phase I and II trials. Expert Opin Biol Ther 1, 525–538 (2001).

2. Kirn, D. H. & Thorne, S. H. Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer. Nat Rev Cancer 9, 64–71 (2009).

3. Sborov, D. W. et al. A phase I trial of single-agent reolysin in patients with relapsed multiple myeloma. Clin Cancer Res 20, 5946–5955 (2014).

4. Kawashima, T. et al. Telomerase-specific replication-selective virotherapy for human cancer. Clin Cancer Res 10, 285–292 (2004).

5. Nemunaitis, J. et al. A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors. Mol Ther 18, 429–434 (2010).

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging delivery strategy for oncolytic virotherapy;Molecular Therapy: Oncology;2024-06

2. Nanotechnology and nano-sized tools: Newer approaches to circumvent oncolytic adenovirus limitations;Pharmacology & Therapeutics;2024-04

3. An oncolytic virus–T cell chimera for cancer immunotherapy;Nature Biotechnology;2024-02-09

4. Viral therapy for targeted drug delivery to cancers: Recent advances, clinical and regulatory perspectives;Journal of Drug Delivery Science and Technology;2024-02

5. Progress in oncolytic viruses modified with nanomaterials for intravenous application;Cancer Biology & Medicine;2023-11-24